STATEMENT: Senate votes for groundbreaking provisions to save billions in prescription drug costs

WASHINGTON – The Inflation Reduction Act just passed by the U.S. Senate provides powerful tools for the government to address high drug prices. Federal legislators identified ways to address drug costs that will save close to $240 billion over 10 years and also relieve the burden of the high cost of medications for many Americans. Next, the U.S. House of Representatives must pass the bill for it to become law.